Differential regulation of lung endothelial permeability in vitro and in situ

Cellular Physiology and Biochemistry

Volumn 34, Issue 1, 2014, Pages 1-19

  Uhlig, Stefan ^a   Yang, Yang ^a   Waade, Josephine ^a   Wittenberg, Claudia ^b   Babendreyer, Aaron ^a   Kuebler, Wolfgang M ^b,c  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Calcium; Endothelial cells; LPS; Platelet activating factor; Pulmonary edema; Pulmonary endothelial cells; Rho kinase; Sphingosine 1 phosphate; Thrombin; TNF; Vascular permeability

Indexed keywords

LIPOPOLYSACCHARIDE; RHO KINASE; SPHINGOSINE 1 PHOSPHATE; THROMBIN; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA; LYSOPHOSPHOLIPID; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE;

BLOOD VESSEL PERMEABILITY; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CELL MEMBRANE PERMEABILITY; ENDOTHELIUM CELL; HUMAN; IN VITRO STUDY; LUNG EDEMA; LUNG ENDOTHELIUM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; ANALOGS AND DERIVATIVES; ANIMAL; CAPILLARY PERMEABILITY; CYTOLOGY; LUNG; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; CALCIUM CELL LEVEL; MONOLAYER CULTURE; REGULATORY MECHANISM;

ANIMALS; CAPILLARY PERMEABILITY; ENDOTHELIAL CELLS; HUMANS; LUNG; LYSOPHOSPHOLIPIDS; PLATELET ACTIVATING FACTOR; PULMONARY EDEMA; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION; SPHINGOSINE; THROMBIN;

EID: 84903985622     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000362980     Document Type: Review

References (159)

1. Staverman AJ: Non-equilibrium thermodynamics of membrane processes. Trans Faraday Soc 1952;48:176-185.
2. Qiao RL, Bhattacharya J: Segmental barrier properties of the pulmonary microvascular bed. J Appl Physiol 1991;71:2152-2159.
3. Yin J, Hoffmann J, Kaestle SM, Neye N, Wang L, Baeurle J, Liedtke W, Wu S, Kuppe H, Pries AR, Kuebler WM: Negative-feedback loop attenuates hydrostatic lung edema via a cGMP-dependent regulation of transient receptor potential vanilloid 4. Circ Res 2008;102:966-974. (Pubitemid 351591552)
4. Jian MY, King JA, Al-Mehdi AB, Liedtke W, Townsley MI: High vascular pressure-induced lung injury requires P450 epoxygenase-dependent activation of TRPV4. Am J Respir Cell Mol Biol 2008;38:386-392. (Pubitemid 351758684)
5. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med 2000;342:1334-1349. (Pubitemid 30408719)
6. Vestweber D: VE-cadherin: The major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol 2008;28:223-232. (Pubitemid 351161193)
7. Pries AR, Kuebler WM: Normal endothelium. Handb Exper Pharmacol 2006:1-40.
8. Regan ER, Aird WC: Dynamical systems approach to endothelial heterogeneity. Circ Res 2012;111:110-130.
9. Aird WC: Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res 2007;100:158-173. (Pubitemid 46208717)
10. Michel CC: Capillary permeability and how it may change. J Physiol 1988;404:1-29.
11. Kuebler WM, Yang Y, Samapati R, Uhlig S: Vascular barrier regulation by PAF, ceramide, caveolae, and NO-an intricate signaling network with discrepant effects in the pulmonary and systemic vasculature. Cell Physiol Biochem 2010;26:29-40.
12. Maron MB: Differential effects of histamine on protein permeability in dog lung and forelimb. Am J Physiol 1982;242:H565-572.
13. Farhi LE, Sheehan DW: Pulmonary circulation and systemic circulation: Similar problems, different solutions. Adv Exp Med Biol 1990;277:579-586.
14. Birukova AA, Smurova K, Birukov KG, Kaibuchi K, Garcia JG, Verin AD: Role of Rho GTPases in thrombin-induced lung vascular endothelial cells barrier dysfunction. Microvasc Res 2004;67:64-77. (Pubitemid 38050225)
15. Rajagopalan LE, Davies MS, Kahn LE, Kornmeier CM, Shimada H, Steiner TA, Zweifel BS, Wendling JM, Payne MA, Loeffler RF, Case BL, Norton MB, Parikh MD, Nemirovskiy OV, Mourey RJ, Masferrer JL, Misko TP, Kolodziej SA: Biochemical, cellular, and anti-inflammatory properties of a potent, selective, orally bioavailable benzamide inhibitor of Rho kinase activity. J Pharmacol Exp Ther 2010;333:707-716.
16. Kasper B, Brandt E, Ernst M, Petersen F: Neutrophil adhesion to endothelial cells induced by platelet factor 4 requires sequential activation of ras, syk, and JNK MAP kinases. Blood 2006;107:1768-1775. (Pubitemid 43289352)
17. Abraham E, Carmody A, Shenkar R, Arcaroli J: Neutrophils as early immunologic effectors in hemorrhage-or endotoxemia-induced acute lung injury. Am J Physiol Lung Cell MolPhysiol 2000;279:L1137-L1145. (Pubitemid 32009500)
18. Till GO, Johnson KJ, Kunkel R, Ward PA: Intravacular activation of complement and acute lung injury. J Clin Invest 1982;62:1126-1135.
19. Looney MR, Su X, Van Ziffle JA, Lowell CA, Matthay MA: Neutrophils and their FC gamma receptors are essential in a mouse model of transfusion-related acute lung injury. J Clin Invest 2006;116:1615-1623.
20. Koksel O, Yildirim C, Tiftik RN, Kubat H, Tamer L, Cinel L, Kaplan MB, Degirmenci U, Ozdulger A, Buyukafsar K: Rho-kinase (Rock-1 and Rock-2) upregulation in oleic acid-induced lung injury and its restoration by Y-27632. Eur J Pharmacol 2005;510:135-142. (Pubitemid 40312399)
21. Tasaka S, Koh H, Yamada W, Shimizu M, Ogawa Y, Hasegawa N, Yamaguchi K, Ishii Y, Richer SE, Doerschuk CM, Ishizaka A: Attenuation of endotoxin-induced acute lung injury by the Rho-associated kinase inhibitor, Y-27632. Am J Respir Cell Mol Biol 2005;32:504-510. (Pubitemid 40770128)
22. Uhlig S, von Bethmann AN: Determination of vascular compliance, interstitial compliance, and capillary filtration coefficient in rat isolated perfused lungs. J Pharmacol Tox Methods 1997;37:119-127. (Pubitemid 27323204)
23. Uhlig S: The isolated perfused lung; in Uhlig S, Taylor AE (eds): Methods in pulmonary pharmacology. Basel, Birkhäuser, 1998, pp 29-55.
24. Kuebler WM, Parthasarathi K, Lindert J, Bhattacharya J: Real-time lung microscopy. J Appl Physiol 2007;102:1255-1264. (Pubitemid 46377053)
25. Lindner K: Regulation of vascular permeability in the lung by ceramide: Research Center Borstel, University of Lübeck, 2005, Ph.D. thesis.
26. Uhlig S, Lindner K: Novel mechanisms of endothelial cell permeability in the lung. Lessons from studies with intact lungs and animals.; in Tooke J, Shore A, Whatmore J (eds): The microcirculation and vascular biology. Bologna, Monduzi Editore, 2002, pp 221-234.
27. Vandenbroucke E, Mehta D, Minshall R, Malik AB: Regulation of endothelial junctional permeability. Ann N Y Acad Sci 2008;1123:134-145. (Pubitemid 351431312)
28. Uhlig S, Göggel R, Engel S: Mechanisms of platelet-activating factor (PAF)-mediated responses in the lung. PharmacolRep 2005;57:S206-221.
29. Knezevic II, Predescu SA, Neamu RF, Gorovoy MS, Knezevic NM, Easington C, Malik AB, Predescu DN: Tiam1 and rac1 are required for platelet-activating factor-induced endothelial junctional disassembly and increase in vascular permeability. J Biol Chem 2009;284:5381-5394.
30. Göggel R, Winoto-Morbach S, Vielhaber G, Imai Y, Lindner K, Brade L, Brade H, Ehlers S, Slutsky AS, Schütze S, Gulbins E, Uhlig S: PAF-mediated pulmonary edema: A new role for acid sphingomyelinase and ceramide. Nat Med 2004;10:155-160. (Pubitemid 38524885)
31. Yang Y, Yin J, Baumgartner W, Samapati R, Solymosi EA, Reppien E, Kuebler WM, Uhlig S: Platelet-activating factor reduces endothelial NO production-role of acid sphingomyelinase. Eur Respir J 2010;36:417-427.
32. Samapati R, Yang Y, Yin J, Stoerger C, Arenz C, Dietrich A, Gudermann T, Adam D, Wu S, Freichel M, Flockerzi V, Uhlig S, Kuebler WM: Lung endothelial Ca2+ and permeability response to platelet-activating factor is mediated by acid sphingomyelinase and transient receptor potential classical 6. Am J Respir Crit Care Med 2012;185:160-170.
33. Yang Y, Uhlig S: The role of sphingolipids in respiratory disease. Ther Adv Respir Dis 2011;5:325-344.
34. Ludwig A, Sommer A, Uhlig S: Assessment of endothelial permeability and leukocyte transmigration in human endothelial cell monolayers. Methods Mol Biol 2011;763:319-332.
35. Dodam JR, Olson NC, Friedman M: Differential effects of tumor necrosis factor-a and platelet-activating factor on bovine pulmonary artery endothelial cells in vitro. ExpLung Res 1994;20:131-141. (Pubitemid 24136506)
36. Bussolino F, Camussi G, Aglietta M, Braquet P, Bosia A, Pescarmona G, Sanavio F, D'Urso N, Marchisio PC: Human endothelial cells are target for platelet-activating factor. I. Platelet-activating factor induces changes in cytoskeleton structures. J Immunol 1987;139:2439-2446. (Pubitemid 17152146)
37. Predescu S, Knezevic I, Bardita C, Neamu RF, Brovcovych V, Predescu D: Platelet activating factor-induced ceramide micro-domains drive endothelial NOS activation and contribute to barrier dysfunction. PloS One 2013;8:e75846.
38. Göggel R, Uhlig S: The inositol trisphosphate pathway mediates platelet-activating-factor-induced pulmonary oedema. Eur RespirJ 2005;25:849-857. (Pubitemid 40667683)
39. Adamson RH, Zeng M, Adamson GN, Lenz JF, Curry FE: PAF-and bradykinin-induced hyperpermeability of rat venules is independent of actin-myosin contraction. Am J Physiol Heart Circ Physiol 2003;285:H406-417. (Pubitemid 36736456)
40. Waypa GB, Vincent PA, Morton CA, Minnear FL: Thrombin increases fluid flux in isolated rat lungs by a hemodynamic and not a permeability mechanism. J Appl Physiol 1996;80:1197-1204. (Pubitemid 26118521)
41. Horgan MJ, Fenton JW, 2nd, Malik AB: Alpha-thrombin-induced pulmonary vasoconstriction. J Appl Physiol 1987;63:1993-2000.
42. Lindner K, Uhlig U, Uhlig S: Ceramide alters endothelial cell permeability by a nonapoptotic mechanism. Br J Pharmacol 2005;145:132-140. (Pubitemid 40675557)
43. Curry FR, Adamson RH: Vascular permeability modulation at the cell, microvessel, or whole organ level: Towards closing gaps in our knowledge. Cardiovasc Res 2010;87:218-229.
44. Kim MH, Curry FR, Simon SI: Dynamics of neutrophil extravasation and vascular permeability are uncoupled during aseptic cutaneous wounding. Am J Physiol Cell Physiol 2009;296:C848-856.
45. Uchiba M, Okajima K, Murakami K, Okabe H, Takatsuki K: Endotoxin-induced pulmonary vascular injury is mainly mediated by activated neutrophils in rats. Thromb Res 1995;78:117-125.
46. Vogel SM, Gao X, Mehta D, Ye RD, John TA, Andrade-Gordon P, Tiruppathi C, Malik AB: Abrogation of thrombin-induced increase in pulmonary microvascular permeability in PAR-1 knockout mice. Physiol Genomics 2000;4:137-145. (Pubitemid 33676689)
47. Troyanovsky B, Alvarez DF, King JA, Schaphorst KL: Thrombin enhances the barrier function of rat microvascular endothelium in a PAR-1-dependent manner. Am J Physiol Lung Cell Mol Physiol 2008;294:L266-275. (Pubitemid 351253363)
48. Parthasarathi K, Ichimura H, Monma E, Lindert J, Quadri S, Issekutz A, Bhattacharya J: Connexin 43 mediates spread of Ca2+-dependent proinflammatory responses in lung capillaries. J Clin Invest 2006;116:2193-2200. (Pubitemid 44162328)
49. Parker JC, Townsley MI: Evaluation of lung injury in rats and mice. Am J Physiol Lung Cell Mol Physiol 2004;286:L231-246. (Pubitemid 38129502)
50. Uhlig S, von Bethmann AN: Determination of vascular compliance, interstitial compliance and capillary filtration coefficient in isolated perfused rat lungs. J Pharm Tox Meth 1997;32:119-127. (Pubitemid 27323204)
51. Goldblum SE, Hennig B, Jay M, Yoneda K, McClain CJ: Tumor necrosis factor-a-induced pulmonary vascular endothelial injury. Infect Immun 1989;57:1218-1226. (Pubitemid 19087870)
52. Petrache I, Verin AD, Crow MT, Birukova A, Liu F, Garcia JG: Differential effect of MLC kinase in TNF-alpha-induced endothelial cell apoptosis and barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 2001;280:L1168-1178.
53. Brett J, Gerlach H, Nawroth P, Steinberg S, Godman G, Stern D: Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins. J Exp Med 1989;169:1977-1991. (Pubitemid 19162960)
54. Nwariaku FE, Rothenbach P, Liu Z, Zhu X, Turnage RH, Terada LS: Rho inhibition decreases TNF-induced endothelial mapk activation and monolayer permeability. J Appl Physiol 2003;95:1889-1895. (Pubitemid 37310372)
55. Naikawadi RP, Cheng N, Vogel SM, Qian F, Wu D, Malik AB, Ye RD: A critical role for phosphatidylinositol (3,4,5)-trisphosphate-dependent rac exchanger 1 in endothelial junction disruption and vascular hyperpermeability. Circ Res 2012;111:1517-1527.
56. Shao M, Yue Y, Sun GY, You QH, Wang N, Zhang D: Caveolin-1 regulates rac1 activation and rat pulmonary microvascular endothelial hyperpermeability induced by TNF-alpha. PloS One 2013;8:e55213.
57. Partridge CA, Jeffrey JJ, Malik AB: A 96-kda gelatinase induced by TNF-alpha contributes to increased microvascular endothelial permeability. Am J Physiol 1993;265:L438-447.
58. Bove K, Neumann P, Gertzberg N, Johnson A: Role of ecNOS-derived NO in mediating TNF-induced endothelial barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 2001;280:L914-922.
59. Mong PY, Petrulio C, Kaufman HL, Wang Q: Activation of Rho kinase by TNF-alpha is required for JNK activation in human pulmonary microvascular endothelial cells. J Immunol 2008;180:550-558.
60. Ferro T, Neumann P, Gertzberg N, Clements R, Johnson A: Protein kinase C-alpha mediates endothelial barrier dysfunction induced by TNFa. Am J Physiol Lung Cell Mol Physiol 2000;278:L1107-L1117. (Pubitemid 30439233)
61. Petrache I, Birukova A, Ramirez SI, Garcia JG, Verin AD: The role of the microtubules in tumor necrosis factor-alpha-induced endothelial cell permeability. Am J Respir Cell Mol Biol 2003;28:574-581. (Pubitemid 36543404)
62. Ferro TJ, Gertzberg N, Selden L, Neumann P, Johnson A: Endothelial barrier dysfunction and p42 oxidation induced by TNF-alpha are mediated by nitric oxide. Am J Physiol 1997;272:L979-988.
63. Neumann P, Gertzberg N, Vaughan E, Weisbrot J, Woodburn R, Lambert W, Johnson A: Peroxynitrite mediates TNF-alpha-induced endothelial barrier dysfunction and nitration of actin. Am J Physiol Lung Cell Mol Physiol 2006;290:L674-L684. (Pubitemid 43725072)
64. Angelini DJ, Hyun SW, Grigoryev DN, Garg P, Gong P, Singh IS, Passaniti A, Hasday JD, Goldblum SE: TNF-alpha increases tyrosine phosphorylation of vascular endothelial cadherin and opens the paracellular pathway through fyn activation in human lung endothelia. Am J Physiol Lung Cell Mol Physiol 2006;291:L1232-1245. (Pubitemid 44904530)
65. Watanabe K, Tanaka H, Wen FQ, Yoshida M: Effect of cytokines on thrombin-stimulated increases in intracellular calcium and PGI2 production by cultured human umbilical vein endothelial cells. Cellular Signall 1996;8:247-251. (Pubitemid 26245250)
66. Yan W, Tiruppathi C, Qiao R, Lum H, Malik AB: Tumor necrosis factor decreases thrombin receptor expression in endothelial cells. J Cell Physiol 1996;166:561-567. (Pubitemid 26095482)
67. Kuebler WM, Parthasarathi K, Wang PM, Bhattacharya J: A novel signaling mechanism between gas and blood compartments of the lung. J Clin Invest 2000;105:905-913. (Pubitemid 30203063)
68. Parthasarathi K, Ichimura H, Quadri S, Issekutz A, Bhattacharya J: Mitochondrial reactive oxygen species regulate spatial profile of proinflammatory responses in lung venular capillaries. J Immunol 2002;169:7078-7086. (Pubitemid 36899296)
69. Stephens KE, Ishizaka A, Larrik JW, Raffin TA: Tumor necrosis factor causes increased pulmonary permeability and edema. Am Rev Respir Dis 1988;137:1364-1370.
70. Johnson J, Brigham KL, Jesmok G, Meyrick B: Morphologic changes in lungs of anesthetized sheep following intravenous infusion of recombinant tumor necrosis factor alpha. Am Rev Respir Dis 1991;144:179-186.
71. Bonsignore MR, Valenti A, Spatafora M: Tumor necrosis factor-alpha does not cause lung edema in rabbits. J Appl Physiol 1992;73:173-178.
72. Reiss LK, Adam D, Uhlig S: Acid sphingomyelinase-deficient mice are protected from the lethal cardiovascular effects in TNF-induced septic shock. NS Arch Pharmacol 2012;385:74-75.
73. Rothstein JL, Schreiber H: Synergy between tumor necrosis factor and bacterial products cause hemorrhagic necrosis and lethal shock in normal mice. Proc Natl Acad Sci 1988;85:607-611. (Pubitemid 18059319)
74. Gatti S, Faggioni R, Echtenacher B, Ghezzi P: Role of tumour necrosis factor and reactive oxygen intermediates in lipopolysaccharide-induced pulmonary oedema and lethality. Clin Exp Immunol 1993;91:456-461. (Pubitemid 23074152)
75. Lechner AJ, Johanns CA, Matushak GM: A recombinant tumor necrosis factor-ap80 receptor:Fc fusion protein decreases circulating bioactive tumor necrosis factor-abut not lung injury or mortality during immunosuppression- related gram-negative bacteremia. J Crit Care 1997;12:28-38. (Pubitemid 27144094)
76. Ryan AJ, McCoy DM, McGowan SE, Salome RG, Mallampalli RK: Alveolar sphingolipids generated in response to TNF-a modifies surfactant biophysical activity. J Appl Physiol 2003;94:253-258. (Pubitemid 36014320)
77. Dreymueller D, Martin C, Kogel T, Pruessmeyer J, Hess FM, Horiuchi K, Uhlig S, Ludwig A: Lung endothelial ADAM17 regulates the acute inflammatory response to lipopolysaccharide. EMBO Mol Med 2012;4:412-423.
78. Schulman CI, Wright JK, Nwariaku F, Sarosi G, Turnage RH: The effect of tumor necrosis factor-alpha on microvascular permeability in an isolated, perfused lung. Shock 2002;18:75-81.
79. Hocking DC, Phillips PG, Ferro TJ, Johnson A: Mechanisms of pulmonary edema induced by tumor necrosis factor-a. Circ Res 1990;67:68-77. (Pubitemid 20223728)
80. Lo SK, Everitt J, Gu J, Malik AB: Tumor necrosis factor mediates experimental pulmonary edema by ICAM-1 and CD18-dependent mechanisms. J Clin Invest 1992;89:981-988.
81. Horgan MJ, Palace GP, Everitt JE, Malik AB: TNF-alpha release in endotoxemia contributes to neutrophil-dependent pulmonary edema. Am J Physiol 1993;264:H1161-H1165. (Pubitemid 23115289)
82. Hattar K, Oppermann S, Ankele C, Weissmann N, Schermuly RT, Bohle RM, Moritz R, Krogel B, Seeger W, Grimminger F, Sibelius U, Grandel U: C-ANCA-induced neutrophil-mediated lung injury: A model of acute Wegener's granulomatosis. Eur Respir J 2010;36:187-195.
83. Fu P, Birukova AA, Xing J, Sammani S, Murley JS, Garcia JG, Grdina DJ, Birukov KG: Amifostine reduces lung vascular permeability via suppression of inflammatory signalling. Eur Respir J 2009;33:612-624.
84. Joshi AD, Dimitropoulou C, Thangjam G, Snead C, Feldman S, Barabutis N, Fulton D, Hou Y, Kumar S, Patel V, Gorshkov B, Verin AD, Black SM, Catravas JD: Heat shock protein 90 inhibitors prevent LPS-induced endothelial barrier dysfunction by disrupting RhoA signaling. Am J Respir Cell Mol Biol 2014;50:170-179.
85. Xing J, Wang Q, Coughlan K, Viollet B, Moriasi C, Zou MH: Inhibition of AMP-activated protein kinase accentuates lipopolysaccharide-induced lung endothelial barrier dysfunction and lung injury in vivo. Am J Pathol 2013;182:1021-1030.
86. Xing J, Birukova AA: Anp attenuates inflammatory signaling and Rho pathway of lung endothelial permeability induced by LPS and TNFalpha. Microvasc Res 2010;79:56-62.
87. Umapathy NS, Zemskov EA, Gonzales J, Gorshkov BA, Sridhar S, Chakraborty T, Lucas R, Verin AD: Extracellular beta-nicotinamide adenine dinucleotide (beta-NAD) promotes the endothelial cell barrier integrity via PKA-and EPAC1/Rac1-dependent actin cytoskeleton rearrangement. J Cell Physiol 2010;223:215-223.
88. Chatterjee A, Snead C, Yetik-Anacak G, Antonova G, Zeng J, Catravas JD: Heat shock protein 90 inhibitors attenuate LPS-induced endothelial hyperpermeability. Am J Physiol Lung Cell Mol Physiol 2008;294:L755-763. (Pubitemid 351520109)
89. Birukova AA, Xing J, Fu P, Yakubov B, Dubrovskyi O, Fortune JA, Klibanov AM, Birukov KG: Atrial natriuretic peptide attenuates LPS-induced lung vascular leak: Role of PAK1. Am J Physiol Lung Cell Mol Physiol 2010;299:L652-663.
90. Dudek SM, Munoz NM, Desai A, Osan CM, Meliton AY, Leff AR: Group V phospholipase A2 mediates barrier disruption of human pulmonary endothelial cells caused by LPS in vitro. Am J Respir Cell Mol Biol 2011;44:361-368.
91. Chen W, Pendyala S, Natarajan V, Garcia JG, Jacobson JR: Endothelial cell barrier protection by simvastatin: GTPase regulation and NADPH oxidase inhibition. Am J Physiol Lung Cell Mol Physiol 2008;295:L575-583.
92. Matute-Bello G, Frevert CW, Martin TR: Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol 2008;295:L379-399.
93. Heflin AC, Brigham KL: Prevention by granulocyte depletion of increased vascular permeability of sheep lung following endotoxemia. J Clin Invest 1981;68:1253-1260. (Pubitemid 12235026)
94. Kopaniak MM, Movat HZ: Kinetics of acute inflammation induced by eschericia coli in rabbits. II. The effect of hyperimmunization, complement depletion, and depletion of leuokocytes. Am J Pathol 1983;110:13-29. (Pubitemid 13170308)
95. Chang SW, Feddersen CO, Henson PM, Voelkel NF: Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. J Clin Invest 1987;79:1498-1509. (Pubitemid 17099656)
96. Chignard M, Balloy V: Neutrophil recruitment and increased permeability during acute lung injury induced by lipopolysaccharide. Am J Physiol Lung Cell Mol Physiol 2000;279:L1083-L1090. (Pubitemid 32009494)
97. Siore AM, Parker RE, Stecenko AA, Cuppels C, McKean M, Christman BW, Cruz-Gervis R, Brigham KL: Endotoxin-induced acute lung injury requires interaction with the liver. Am J Physiol Lung Cell Mol Physiol 2005;289:L769-L776. (Pubitemid 41504408)
98. Uhlig S, Brasch F, Wollin L, Fehrenbach H, Richter J, Wendel A: Functional and fine structural changes in isolated rat lungs challenged with endotoxin ex vivo and in vitro. Am J Pathol 1995;146:1235-1247.
99. Winn R, Nickelson S, Rice CL: Fluid filtration coefficient of isolated goat lungs was unchanged by endotoxin. J Appl Physiol 1988;64:2463-2467.
100. Chian CF, Chiang CH, Yuan-Jung C, Chuang CH, Liu SL, Yi-Han J, Zhang H, Ryu JH: Apocynin attenuates lipopolysaccharide-induced lung injury in an isolated and perfused rat lung model. Shock 2012;38:196-202.
101. Welsh CH, Lien DC, Worthen GS, Henson PM, Weil JV: Endotoxin-pretrated neutrophils increase pulmonary vascular permeability in dogs. J Appl Physiol 1989;66:112-119. (Pubitemid 19056065)
102. Haimovitz-Friedman A, Cordon-Cardo C, Bayoumy S, Garzotto M, McLoughlin M, Gallily R, Edwards CK, Schuchman EH, Fuks Z, Kolesnick R: Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J Exp Med 1997;189:1831-1841. (Pubitemid 27524593)
103. Künstle G, Leist M, Uhlig S, Revesz L, Feifel R, MacKenzie A, Wendel A: ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or by TNF-alpha. Immunol Lett 1997;55:5-10. (Pubitemid 27117487)
104. Uhlig S, Yang Y: Sphingolipids in acute lung injury. Handbook Exper Pharmacol 2013:227-246.
105. Wang L, Dudek SM: Regulation of vascular permeability by sphingosine 1-phosphate. Microvasc Res 2009;77:39-45.
106. Szczepaniak WS, Pitt BR, McVerry BJ: S1P2 receptor-dependent Rho-kinase activation mediates vasoconstriction in the murine pulmonary circulation induced by sphingosine 1-phosphate. Am J Physiol Lung Cell Mol Physiol 2010;299:L137-145.
107. Ota H, Beutz MA, Ito M, Abe K, Oka M, McMurtry IF: S1P(4) receptor mediates S1P-induced vasoconstriction in normotensive and hypertensive rat lungs. Pulm Circul 2011;1:399-404.
108. Sanchez T, Skoura A, Wu MT, Casserly B, Harrington EO, Hla T: Induction of vascular permeability by the sphingosine-1-phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN. Arterioscler Thromb Vasc Biol 2007;27:1312-1318. (Pubitemid 46809419)
109. Shea BS, Brooks SF, Fontaine BA, Chun J, Luster AD, Tager AM: Prolonged exposure to sphingosine 1-phosphate receptor-1 agonists exacerbates vascular leak, fibrosis, and mortality after lung injury. Am J Respir Cell Mol Biol 2010;43:662-673.
110. Uhlig S, Wollin L, Wendel A: Contributions of thromboxane and leukotrienes to PAF-induced impairment of lung function in the rat. J Appl Physiol 1994;77:262-269. (Pubitemid 24226144)
111. Wu S, Jian MY, Xu YC, Zhou C, Al-Mehdi AB, Liedtke W, Shin HS, Townsley MI: Ca2+ entry via alpha1G and TRPV4 channels differentially regulates surface expression of P-selectin and barrier integrity in pulmonary capillary endothelium. Am J Physiol Lung Cell Mol Physiol 2009;297:L650-657.
112. Alvarez DF, King JA, Weber D, Addison E, Liedtke W, Townsley MI: Transient receptor potential vanilloid 4-mediated disruption of the alveolar septal barrier: A novel mechanism of acute lung injury. Circ Res 2006;99:988-995. (Pubitemid 44657802)
113. Hamanaka K, Jian MY, Weber DS, Alvarez DF, Townsley MI, Al-Mehdi AB, King JA, Liedtke W, Parker JC: TRPV4 initiates the acute calcium-dependent permeability increase during ventilator-induced lung injury in isolated mouse lungs. Am J Physiol Lung Cell Mol Physiol 2007;293:L923-L932. (Pubitemid 47572240)
114. Ying X, Minamiya Y, Fu C, Bhattacharya J: Ca2+ waves in lung capillary endothelium. Circ Res 1996;79:898-908. (Pubitemid 26317840)
115. Kuebler WM, Ying X, Bhattacharya J: Pressure-induced endothelial Ca2+ oscillations in lung capillaries. Am J Physiol Lung Cell Mol Physiol 2002;282:L917-L923. (Pubitemid 34654607)
116. Naruse K, Sokabe M: Involvement of stretch-activated ion channels in Ca2+ mobilization to mechanical stretch in endothelial cells. Am J Physiol 1993;264:C1037-1044. (Pubitemid 23118127)
117. Lin AY, Rui YC: Platelet-activating factor induced calcium mobilization and phosphoinositide metabolism in cultured bovine cerebral microvascular endothelial cells. Biochim Biophys Acta 1994;1224:323-328.
118. Ito S, Suki B, Kume H, Numaguchi Y, Ishii M, Iwaki M, Kondo M, Naruse K, Hasegawa Y, Sokabe M: Actin cytoskeleton regulates stretch-activated Ca2+ influx in human pulmonary microvascular endothelial cells. Am J Respir Cell Mol Biol 2010;43:26-34.
119. Hirafuji M, Maeyama K, Watanabe T, Ogura Y: Transient increase of cytosolic free calcium in cultured human vascular endothelial cells by platelet-activating factor. Biochem Biophys Res Commun 1988;154:910-917.
120. Sutovsky P, Flechon JE, Flechon B, Motlik J, Peynot N, Chesne P, Heyman Y: Dynamic changes of gap junctions and cytoskeleton during in vitro culture of cattle oocyte cumulus complexes. Biol Reprod 1993;49:1277-1287. (Pubitemid 23342121)
121. Revel JP, Yee AG, Hudspeth AJ: Gap junctions between electrotonically coupled cells in tissue culture and in brown fat. Proc Natl Acad Sci U S A 1971;68:2924-2927.
122. Morel NML, Petruzzo PP, Hechtmann HB, Shepro: Inflammatory agonists that increase microvascular permeability in vivo stimulate pulmonary microvessel endothelial cell contraction. Inflammation 1990; 14:571-583. (Pubitemid 20350857)
123. Birukov KG, Birukova AA, Dudek SM, Verin AD, Crow MT, Zhan X, DePaola N, Garcia JG: Shear stress-mediated cytoskeletal remodeling and cortactin translocation in pulmonary endothelial cells. Am J Respir Cell Mol Biol 2002;26:453-464. (Pubitemid 34253930)
124. Kerem A, Yin J, Kaestle SM, Hoffmann J, Schoene AM, Singh B, Kuppe H, Borst MM, Kuebler WM: Lung endothelial dysfunction in congestive heart failure: Role of impaired Ca2+ signaling and cytoskeletal reorganization. Circ Res 2010;106:1103-1116.
125. Yao HY, Chen L, Xu C, Wang J, Chen J, Xie QM, Wu X, Yan XF: Inhibition of rac activity alleviates lipopolysaccharide-induced acute pulmonary injury in mice. Biochim Biophys Acta 2011;1810:666-674.
126. Adamson RH, Curry FE, Adamson G, Liu B, Jiang Y, Aktories K, Barth H, Daigeler A, Golenhofen N, Ness W, Drenckhahn D: Rho and Rho kinase modulation of barrier properties: Cultured endothelial cells and intact microvessels of rats and mice. J Physiol 2002;539:295-308. (Pubitemid 35190116)
127. Gorovoy M, Neamu R, Niu J, Vogel S, Predescu D, Miyoshi J, Takai Y, Kini V, Mehta D, Malik AB, Voyno-Yasenetskaya T: RhoGDI-1 modulation of the activity of monomeric RhoGTPase RhoA regulates endothelial barrier function in mouse lungs. Circ Res 2007;101:50-58. (Pubitemid 47094623)
128. Krishnan R, Klumpers DD, Park CY, Rajendran K, Trepat X, van Bezu J, van Hinsbergh VW, Carman CV, Brain JD, Fredberg JJ, Butler JP, van Nieuw Amerongen GP: Substrate stiffening promotes endothelial monolayer disruption through enhanced physical forces. Am J Physiol Cell Physiol 2011;300:C146-154.
129. Huynh J, Nishimura N, Rana K, Peloquin JM, Califano JP, Montague CR, King MR, Schaffer CB, Reinhart-King CA: Age-related intimal stiffening enhances endothelial permeability and leukocyte transmigration. Sci Transl Med 2011;3:112ra122.
130. Birukova AA, Tian X, Cokic I, Beckham Y, Gardel ML, Birukov KG: Endothelial barrier disruption and recovery is controlled by substrate stiffness. Microvasc Res 2013;87:50-57.
131. Liu F, Mih JD, Shea BS, Kho AT, Sharif AS, Tager AM, Tschumperlin DJ: Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression. J Cell Biol 2010;190:693-706.
132. Suki B, Ito S, Stamenovic D, Lutchen KR, Ingenito EP: Biomechanics of the lung parenchyma: Critical roles of collagen and mechanical forces. J Appl Physiol 2005;98:1892-1899. (Pubitemid 40570805)
133. Rausch SM, Martin C, Bornemann PB, Uhlig S, Wall WA: Material model of lung parenchyma based on living precision-cut lung slice testing. J Mech Behav Biomed Mater 2011;4:583-592.
134. Bel-Brunon A, Kehl S, Martin C, Uhlig S, Wall WA: Numerical identification method for the non-linear viscoelastic compressible behavior of soft tissue using uniaxial tensile tests and image registration-application to rat lung parenchyma. J Mech Behav Biomed Mater 2014;29:360-374.
135. Robinson KG, Nie T, Baldwin AD, Yang EC, Kiick KL, Akins RE Jr: Differential effects of substrate modulus on human vascular endothelial, smooth muscle, and fibroblastic cells. J Biom Mater Res 2012;100:1356-1367.
136. Michel CC, Curry FE: Microvascular permeability. Physiol Rev 1999;79:703-761. (Pubitemid 29330172)
137. Parker JC, Stevens T, Randall J, Weber DS, King JA: Hydraulic conductance of pulmonary microvascular and macrovascular endothelial cell monolayers. Am J Physiol Lung Cell Mol Physiol 2006;291:L30-37.
138. Hall CN, Garthwaite J: What is the real physiological NO concentration in vivo? Nitric oxide 2009;21:92-103.
139. Yang Y, Schmidt EP: The endothelial glycocalyx: An important regulator of the pulmonary vascular barrier. Tissue Barriers 2013;1: pii: 23494.
140. Durr E, Yu J, Krasinska KM, Carver LA, Yates JR, Testa JE, Oh P, Schnitzer JE: Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture. Nature Biotechnol 2004;22:985-992. (Pubitemid 39014475)
141. D'Alessio A, Al-Lamki RS, Bradley JR, Pober JS: Caveolae participate in tumor necrosis factor receptor 1 signaling and internalization in a human endothelial cell line. Am J Pathol 2005;166:1273-1282. (Pubitemid 40524450)
142. Seebach J, Dieterich P, Luo F, Schillers H, Vestweber D, Oberleithner H, Galla HJ, Schnittler HJ: Endothelial barrier function under laminar fluid shear stress. Lab Invest 2000;80:1819-1831. (Pubitemid 32012751)
143. Muller-Marschhausen K, Waschke J, Drenckhahn D: Physiological hydrostatic pressure protects endothelial monolayer integrity. Am J Physiol Cell Physiol 2008;294:C324-332.
144. Qiu Y, Tarbell JM: Interaction between wall shear stress and circumferential strain affects endothelial cell biochemical production. J Vasc Res 2000;37:147-157. (Pubitemid 30350883)
145. Benjamin LE, Hemo I, Keshet E: A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated byPDGF-B and VEGF. Development 1998;125:1591-1598. (Pubitemid 28256727)
146. Kim YH, Hu H, Guevara-Gallardo S, Lam MT, Fong SY, Wang RA: Artery and vein size is balanced by notch and ephrin B2/EphB4 during angiogenesis. Development 2008;135:3755-3764.
147. Hall SM, Hislop AA, Haworth SG: Origin, differentiation, and maturation of human pulmonary veins. Am J Respir Cell Mol Biol 2002;26:333-340. (Pubitemid 34170059)
148. Hoefer IE, den Adel B, Daemen MJ: Biomechanical factors as triggers of vascular growth. Cardiovasc Res 2013;99:276-283.
149. Liu HB, Zhang J, Xin SY, Liu C, Wang CY, Zhao D, Zhang ZR: Mechanosensitive properties in the endothelium and their roles in the regulation of endothelial function. J Cardiovasc Pharmacol 2013;61:461-470.
150. Madri JA, Williams SK: Capillary endothelial cell cultures: Phenotypic modulation by matrix components. J Cell Biol 1983;97:153-165. (Pubitemid 13076526)
151. Mammoto A, Mammoto T, Ingber DE: Mechanosensitive mechanisms in transcriptional regulation. J Cell Sci 2012;125:3061-3073.
152. Goerdt S, Steckel F, Schulze-Osthoff K, Hagemeier HH, Macher E, Sorg C: Characterization and differential expression of an endothelial cell-specific surface antigen in continuous and sinusoidal endothelial, in skin vascular lesions and in vitro. Exp Cell Biol 1989;57:185-192. (Pubitemid 19261729)
153. Aird WC, Edelberg JM, Weiler-Guettler H, Simmons WW, Smith TW, Rosenberg RD: Vascular bed-specific expression of an endothelial cell gene is programmed by the tissue microenvironment. J Cell Biol 1997;138:1117-1124. (Pubitemid 27386460)
154. Lacorre DA, Baekkevold ES, Garrido I, Brandtzaeg P, Haraldsen G, Amalric F, Girard JP: Plasticity of endothelial cells: Rapid dedifferentiation of freshly isolated high endothelial venule endothelial cells outside the lymphoid tissue microenvironment. Blood 2004;103:4164-4172. (Pubitemid 38685358)
155. Aranguren XL, Agirre X, Beerens M, Coppiello G, Uriz M, Vandersmissen I, Benkheil M, Panadero J, Aguado N, Pascual-Montano A, Segura V, Prosper F, Luttun A: Unraveling a novel transcription factor code determining the human arterial-specific endothelial cell signature. Blood 2013;122:3982-3992.
156. Gonzalez R, Yang YH, Griffin C, Allen L, Tigue Z, Dobbs L: Freshly isolated rat alveolar type I cells, type II cells, and cultured type II cells have distinct molecular phenotypes. AmJPhysiol Lung Cell MolPhysiol 2005;288:L179-L189. (Pubitemid 40023900)
157. Stevens T: Functional and molecular heterogeneity of pulmonary endothelial cells. Proc of the Am Thorac Soc 2011;8:453-457.
158. Birukova AA, Wu T, Tian Y, Meliton A, Sarich N, Tian X, Leff A, Birukov KG: Iloprost improves endothelial barrier function in lipopolysaccharide-induced lung injury. Eur Respir J 2013;41:165-176.
159. Peng X, Hassoun PM, Sammani S, McVerry BJ, Burne MJ, Rabb H, Pearse D, Tuder RM, Garcia JG: Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am J Respir Crit Care Med 2004;169:1245-1251. (Pubitemid 38680403)